Doha, Qatar — Sidra Medicine, a member of Qatar Foundation, has reached a significant milestone in its digital transformation journey, with formal validation of achieving Stage 6 in both HIMSS EMRAM and HIMSS DIAM.

The assessments by HIMSS (Healthcare Information and Management Systems Society) reviewers, positions Sidra Medicine as the first hospital in Qatar to attain EMRAM Stage 6, and the only organisation in the Middle East and Europe to be validated at DIAM Stage 6. It is also the second organisation across the region to reach this level of digital imaging maturity.

Ms. Maha Al Henzab, Executive Director of Information Management & Technology at Sidra Medicine said: “This validation reflects the dedication and collaboration of our clinical, technical, and operational teams. I am very proud of our collective expertise and efforts.  Reaching EMRAM and DIAM Stage 6 strengthens our ability to deliver safe, efficient, and digitally enabled care, while laying a strong foundation for our continued progress toward Stage 7.”

HIMSS EMRAM (Electronic Medical Record Adoption Model) measures how effectively hospitals use electronic medical records to support clinical care, patient safety, and efficient workflows. Reaching Stage 6 reflects advanced use of digital systems, including electronic physician documentation, closed-loop medication administration, and clinical decision support across inpatient and outpatient services.

HIMSS DIAM (Digital Imaging Adoption Model) assesses how diagnostic and enterprise imaging are used to improve quality, consistency, and operational performance. Stage 6 recognises organisations that are using imaging data in advanced, integrated ways to support clinical decision-making and continuous improvement.

As part of the assessment conducted from 15 to 16 December 2025, the reviewers evaluated end-to-end inpatient and outpatient workflows, laboratory and pharmacy processes, closed-loop systems, and complete diagnostic imaging pathways across departments. The assessment also highlighted Sidra Medicine’s use of AI-enabled imaging and 3D printing to support clinical innovation.

Building on this milestone, Sidra Medicine will continue advancing its digital maturity and outcomes-driven improvement as it progresses toward HIMSS EMRAM and DIAM Stage 7.

About Sidra Medicine

Innovating Care. Transforming Lives

From the heart of Qatar, Sidra Medicine, is a private, not-for-profit academic healthcare and research institution for women, children, and young people.

Established by the Qatar Foundation for Education, Science, and Community Development, Sidra Medicine is committed to delivering exceptional patient and family-focused care, conducting innovative biomedical and clinical research, and providing a personalized journey of care and cure and precision medicine specifically for rare and genetic diseases.

To access our specialized healthcare or international patient services, including pediatric care, women's health, and rare disease treatment or to book a consultation at one of our private clinics, please call +974 40033333 or visit our website at http://www.sidra.org.

For more information, follow us on Facebook, Instagram, X and LinkedIn